DOLLY PARTON RETURNS TO PUBLIC EYE TO CELEBRATE OPENING DAY AT DOLLYWOOD . (PHOTO).

Image
 Dolly Parton returns to public eye to celebrate opening day at Dollywood     Dolly Parton made her first public appearance in months to celebrate the opening day of Dollywood in Pigeon Forge, Tennessee, on Friday. The country music icon reflected on the past year, a year after the death of her husband of nearly 60 years, Carl Dean, saying she is “doing good” and has been working to rebuild herself spiritually, emotionally, and physically after grieving and dealing with health issues that kept her from touring. Joined on stage by Dollywood president Eugene Naughton, Parton brought her trademark humor to the crowd, joking about rumors of a new husband while reaffirming her devotion to Dean. She also shared updates on her ongoing projects, including a new Broadway musical and her Dolly’s Life of Many Colors Museum in Nashville. Parton previewed the park’s 41st season, highlighting the upcoming NightFlight Expedition ride, a new “Run Dollywood” race weekend, an updated ...

KENYA HAILS FIRST ROLLOUT OF HIV PREVENTION DRUG LENACAPAVIR. (PHOTO).


 Kenya hails first rollout of HIV prevention drug Lenacapavir


Kenya began administering the first dose of a groundbreaking HIV prevention drug in a Nairobi slum on Thursday.


Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, though it is technically a chemical drug rather than a vaccine because it does not train the immune system.


"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale said during the rollout, AFP reported.


Kenya was among nine African countries selected last year to introduce lenacapavir, which has already been introduced in South Africa, Eswatini and Zambia since December.


There are roughly 1.3 million people living with HIV in Kenya, with the highest burden among those aged 15 to 24.


‘Renewed strength’


"Many of our young people still face the risk of infection... this innovation gives us renewed strength in our national fight against HIV," Duale, said adding that the drug will be free to those receiving it.


Last week, Kenya received its first batch of 21,000 doses through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS.


Lenacapavir offers greater privacy compared to regularly visits to health clinics for treatment, said Carol Njomo, a community health worker in Nairobi's Kawangware area, where the first doses were administered.


"This is an added protection," said Samson Mutua, 27, the first person to receive the injection.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.